Back
Invesco Zacks Multi-Asset Income ETF Vs. Dyne Therapeutics Industry Stock Comparison
Buy
57
CVY
Invesco Zacks Multi-Asset Income ETF
Last Price:
26.40
Seasonality Move:
0.93%
Sell
46
DYN
Dyne Therapeutics
Last Price:
30.40
Seasonality Move:
38.02%
Buy
57
Invesco Zacks Multi-Asset Income ETF (CVY)
is a Buy
Is Invesco Zacks Multi-Asset Income ETF a Buy, Sell or Hold?
- The current Invesco Zacks Multi-Asset Income ETF [CVY] share price is $26.35. The Score for CVY is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- CVY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $30.31. The Score for DYN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- DYN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CVY Stock Price Chart
What is Invesco Zacks Multi-Asset Income ETF's stock price today?
-
The Invesco Zacks Multi-Asset Income ETF share price today is $26.35
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVY is experiencing slight buying pressure.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $30.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.
CVY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 54.1 | Buy |
| Chaikin Money Flow: | 1058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.79 - 26.49) | Buy |
| Bollinger Bands (100): | (25.36 - 26.34) | Buy |
DYN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.91 | Sell |
| Relative Strength Index (14 RSI): | 47.11 | Sell |
| Chaikin Money Flow: | -1019710 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.92 - 33.44) | Sell |
| Bollinger Bands (100): | (31.39 - 42.57) | Sell |
CVY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.4 | Sell |
| 20-day SMA: | 26.08 | Buy |
| 50-day SMA: | 26.07 | Buy |
| 200-day SMA: | 25.41 | Buy |
| 8-day EMA: | 26.32 | Buy |
| 20-day EMA: | 26.19 | Buy |
| 50-day EMA: | 26.07 | Buy |
| 200-day EMA: | 25.26 | Buy |
DYN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.77 | Buy |
| 20-day SMA: | 30.55 | Sell |
| 50-day SMA: | 32.55 | Sell |
| 200-day SMA: | 32.11 | Sell |
| 8-day EMA: | 30.26 | Buy |
| 20-day EMA: | 30.69 | Sell |
| 50-day EMA: | 32.85 | Sell |
| 200-day EMA: | 30.82 | Sell |
Invesco Zacks Multi-Asset Income ETF Earnings Growth & CVY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.10 per share.
Invesco Zacks Multi-Asset Income ETF Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dyne Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||